Egipt - angielski - EDA (Egyptian Drug Authority)

f.hoffman la roche-scientific office - tablet - 7.5 mg

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

roche products limited - midazolam hydrochloride - solution for injection - 10 mg/5ml - benzodiazepine derivatives

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

roche products limited - midazolam hydrochloride - solution for injection - 10 mg/2ml - benzodiazepine derivatives

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - paracetamol; metoclopramide hydrochloride - tablet - 500mg/5 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Singapur - angielski - HSA (Health Sciences Authority)

roche singapore pte. ltd. - midazolam - injection - 5 mg/ml

Bahrajn - angielski - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

al jishi pharmacy - midazolam maleate - film coated tablet - 15

Filipiny - angielski - FDA (Food And Drug Administration)

zuellig pharma corporation; distributor: zuellig pharma corporation - midazolam - film-coated tablet - 15 mg

Filipiny - angielski - FDA (Food And Drug Administration)

roche (philippines) inc.; distributor: zuellig pharma corporation - midazolam (as maleate) - tablet - 15mg

Australia - angielski - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - midazolam hydrochloride, quantity: 5.56 mg/ml (equivalent: midazolam, qty 5 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time; iv for sedation in intensive care units; intermittent administration or continuous infusion; im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - midazolam hydrochloride, quantity: 1.112 mg/ml (equivalent: midazolam, qty 1 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time; iv for sedation in intensive care units; intermittent administration or continuous infusion; im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.